Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Tirzepatide users in the SURMOUNT-1 trial lost up to 22.5% of body weight, substantially more than semaglutide STEP trial results
Individuals considering Tesamorelin therapy should consult a healthcare provider to evaluate its safety and appropriateness for their specific health needs and circumstances
Ozempic: Important Differences To Consider
In the STEP trials (the gold-standard studies for semaglutide efficacy), participants taking the medication for 68 weeks lost an average of 15% of body weight, but the steepest weight loss occurred between months two and four
But many questions remain including its long-term safety profile, effect on lean body mass and bone mineral density, real-world tolerability, and ultimate UK pricing once and if MHRA approval is granted
doi:10.2147/jep.s35396
US$ 26.25
US$ 23.61
US$ 25.61
